Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MGRX Is Launching “PRIME”, Powered By KYZATREX Capsules, For An FDA Approved ORAL #Testosterone Replacement Therapy (#TRT) Product!
Link: https://globenewswire.com/news-release/2023/12/13/2795461/0/en/MANGOCEUTICALS-TO-INTRODUCE-PRIME-POWERED-BY-KYZATREX-%ef%b8%8f-CIII-TESTOSTERONE-UNDECANOATE-CAPSULES-FOR-AN-FDA-APPROVED-ORAL-TESTOSTERONE-REPLACEMENT-THERAPY-TRT-PRODUCT.html
The Dallas Based, Direct-to-Consumer Telemedicine Company Secures Marketing Agreement with Marius Pharmaceuticals Bringing KYZATREX to the Telehealth Market as ‘Prime’ by MangoRx
Dallas, Texas & Raleigh, NC, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (‘GROW’) and erectile dysfunction (ED) drug (‘Mango’), is excited to announce that it has entered into a Marketing Agreement with Marius Pharmaceuticals ("Marius") to market and sell KYZATREX®️, an innovative FDA-approved oral Testosterone Replacement Therapy (TRT) product, under the program, 'PRIME' by MangoRx.
PRIME will be available on MangoRx’s telemedicine platform with an anticipated launch date of January 31, 2024.
KYZATREX, a prescription drug that is used to treat adult men who have low or no testosterone levels due to certain medical conditions, is one of only three FDA approved TRT treatments that is delivered orally--as opposed to the traditional, invasive, and inconvenient injection-based drug delivery protocol. KYZATREX delivers testosterone in a softgel capsule that is absorbed primarily via the lymphatic system, avoiding liver toxicity.
Testosterone deficiency is often first recognized through symptoms of fatigue or low energy, decreased sex drive, lower muscle mass and many other negative downstream impacts. PRIME, powered by KYZATREX, can help men restore Testosterone to normal levels and improve how they feel. In a 6-month open-label clinical study of 139 hypogonadal patients, 88% of patients taking KYZATREX had normal testosterone levels at Day 90 (worst case scenario (WCS) efficacy calculation, excluding Site 104).1 Among study completers (n=127), 96% of KYZATREX patients achieved normal testosterone levels at Day 90.2 With PRIME, MangoRx will expand broad-based consumer access to this innovative therapy.
TRT treatments have traditionally been delivered through intramuscular needle injection, a subcutaneous implant, or a topical gel. These applications have suffered from different drawbacks depending on the delivery method, such as painful administration, uneven absorption, risk of transfer to others, and disruptions to the body's natural diurnal rhythm allowing for peak performance early in the day.
Twice daily oral TRTs offer painless administration, promote steady absorption, lower SHGB levels, increase free T levels to give the body more usable testosterone, and work with the body's natural diurnal rhythm. Oral softgels are also convenient, mess-free, and discreet.
Shalin Shah, CEO of Marius, shared, “This expansion into telehealth marks an important step in the care of Testosterone Deficient patients. Testosterone Deficiency is a serious chronic disease and has been inadequately addressed by previous generations of products. KYZATREX marks a shift in the treatment paradigm and a meaningful opportunity for patients seeking to restore optimal testosterone levels. Marius is excited to partner with MangoRx as an innovative partner in the DTC marketplace. We look forward to the Mango team bringing more awareness around the significance of Testosterone as a metabolic hormone and its role in optimal health for men with Low T.”
PRIME by MangoRx will bring KYZATREX to patients spanning 48 states through the Company’s telemedicine platform, which is optimized to deliver a smooth medical prescription process, including blood work and synchronous telehealth visits with a fully licensed prescribing physician. Orders will be reviewed and, pending approval, fulfilled, then discreetly shipped via MangoRx’s URAC accredited mail order partner pharmacy directly to the patient’s doorstep.
Jacob Cohen, MangoRx’s Co-Founder and CEO, noted, “PRIME represents a critical expansion into a new vertical with massive market potential and very little competition on the consumer side, while remaining completely consistent with our established identity as a company committed to providing new and innovative pharmaceutical based solutions helping men achieve optimal performance in all areas of life. We are extremely fortunate to be working with Marius and to be one of only a few companies with access to this innovative product. With our established marketing and telemedicine infrastructure in place, we are ready to hit the ground running and take PRIME to patients in need across the country next month."
Testosterone deficiency affects approximately four in ten men older than 45 years and 30-50% of men with obesity or type 2 diabetes, according to the Endocrine Society.3,4 Between 10% and 40% of men worldwide suffer from low testosterone levels.5
About MangoRx
MangoRx is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED) and hair growth. Interested consumers can use MangoRx’s telemedicine platform for a smooth experience. Prescription requests will be reviewed by a physician and, if approved, fulfilled and discreetly shipped through MangoRx’s partner compounding pharmacy and right to the patient’s doorstep.
To learn more about MangoRx’s mission and other products, please visit www.MangoRx.com or on social media @Mango.Rx.
About Marius Pharmaceuticals
Marius Pharmaceuticals strives to better the lives of patients by focusing on therapies designed for hypogonadism or Testosterone Deficiency. The company's vision is to holistically improve metabolic health and mitigate significant unnecessary costs to the global healthcare system. For more information, please visit www.mariuspharma.com.
About KYZATREX® (testosterone undecanoate)
KYZATREX is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) and indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone. The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level (≤281 ng/dL) and at least one sign or symptom of testosterone deficiency. In the efficacy population (n=139), 88 percent of hypogonadal men treated with KYZATREX achieved a mean plasma total testosterone concentration (Cavg) over 24 hours within the normal range (222-800 ng/dL) on the final pharmacokinetic (PK) visit of the study at Day 90 (primary endpoint). Based on exploratory endpoints, patients who received KYZATREX reported improvements in symptoms of low testosterone, including quality of life, energy/fatigue, erectile function, sexual intercourse, and mood. The most common side effect reported in ≥2 percent of KYZATREX patients was increased blood pressure (2.6%). The safety and efficacy of KYZATREX in males less than 18 years old have not been established.
$IVDN: Superior Advancement for High Energy Efficiency Insulation Drawing Rising Interest and Commercial Demand; New International Patent Application Accepted to Maximize Marketing Potential
Feature Link:
https://markets.financialcontent.com/startribune/article/getnews-2023-12-28-superior-advancement-for-high-energy-efficiency-insulation-drawing-rising-interest-and-commercial-demand-new-international-patent-application-accepted-to-maximize-marketing-potential-ivdn
From the article:
Very Small Stock Structure of Only 37 Million OS / 16 Million Float
- Sole Maker of Patented Insultex® Insulation Delivering Energy Saving Performance Far Superior to All Competition.
- Unique Evacuated Cell House Wrap Material Provides an Unmatched R-6 Rating Plus a Water Vapor, Air, and Wind Barrier and Other Superior Benefits.
- World International Patent Organization Application Accepted to Maximize Global Marketing Opportunities.
- "Leader in Green Assets" LIG Assets, Inc., in Association with Robert Plarr, Signs Sales and Licensing Agreement with IVDN.
- Insultex House Wrap® Already Being Installed by LIG Assets in Conjunction with Their Plans to Acquire Firm Doing $100-200 Million in Annualized Sales.
- Over a Dozen New Sales Accounts were Added in the Fiscal Fourth Quarter with Orders Being Fulfilled for Superior Insultex® House Wrap.
- New Building Codes Require Higher Insulation Performance and IVDN Meets or Exceeds These New Standards Where Many Competitors Do Not.
- Increased Order Fulfilment Capabilities Recently Added with Plans for Further Enhancement to Handle Increasing Customer Demand.
- New Sales Accounts Include Large-Scale Commercial Modular Construction Firm Guerdon, LLC.
- Greater Energy Savings from Insultex® Insulation Delivers Substantial Economic Gains and Tax Credits for the User and Also Carbon Reduction for the Environment.
- Insider Buying from Board Member with Lockheed Martin & NASA Background.
Hello my friend thank you!!
SPZI 15M VOLUME 10 DAY AVG_91M .01 +4.17%
NHYF is primed for a unicorn run
Hope everyone’s doing well!!!
$KATX .0029 Shell sold recently...Get ready! Still very early here....
RGLG 136K VOLUME 10 DAY AVG_71K .2845 +32.33%
What's with this message?
"What a coincidence… both profiles on the same message….. hey Ockham… why you DM me on Twitter earlier then not answer me back"
You have to give me some time. I was going to answer you back. Having issues logging in though bc of location
RGLG has been on fire. Started buying .04 on way down to .007 area...it actually almost ran 1,000% from .07 after someone sold .007 area.
$BLEG Loading up for Growth-->>>
Secured a $1,000,000 line of credit under a fixed interest rate and confirms there will be no reverse split.
BLEG previously announced it would retire 1.6 Billion shares, $BLEG is not stopping!
https://www.prnewswire.com/news-releases/branded-legacy-inc-secures-1m-line-of-credit-affirms-no-reverse-split-and-previews-upcoming-investor-engagements-301980129.html
You know hacking someone is a criminal offense of 1-5years right? Hope you got what you wanted.
What’s up solar man…. We talk again
What’s up solar man…. We talk again
What a coincidence… both profiles on the same message….. hey Ockham… why you DM me on Twitter earlier then not answer me back
$SOPA Two IPO's on the way!
https://finance.yahoo.com/news/society-pass-inc-nasdaq-sopa-121700152.html
$IVDN (16 Million Float): INSULTEX HOUSE WRAP PAIRS WATER RESISTANCE WITH THERMAL PERFORMANCE
By Layne Deakins
Products for Residential Construction Professionals
Click here:
https://www.residentialproductsonline.com/insultex-house-wrap-pairs-water-resistance-thermal-performance
Also ...
Increasing Orders and Insider Share Purchase; Patented Evacuated Cell Insulation; Innovative Designs: Stock Symbol IVDN
https://www.einpresswire.com/article/637864225/increasing-orders-and-insider-share-purchase-patented-evacuated-cell-insulation-innovative-designs-stock-symbol-ivdn
Ready for some break out OTC
We ready!
Hope everyone’s doing well!
Happy thoughts!!!
$IGEX should be hearing something soon. Recent control change
$GEMZ GEMXX Corporation Reports 2nd Gold Production from the Snow Creek Mine Site in British Columbia, Canada
https://www.globenewswire.com/news-release/2023/09/19/2745612/0/en/GEMXX-Corporation-GEMZ-Reports-2nd-Gold-Production-from-the-Snow-Creek-Mine-Site-in-British-Columbia-Canada.html
NHYF peeps.
Get in, RM…. AI and healthcare
Very thin
Was sold for equity NOT cash.
How r ya buddy? Long time man....I got kill in otcbb again this year brutal year! I m broke now man. Thanks for those tips...on watch....currently I m in eltp
PSYCF Pay Attention people. There are developments (related to recent research of Amanita Muscaria) that will connect this great Mushroom to a BREAKTHROUGH treatment of some kind.
Potential possibility =
https://www.sciencealert.com/brain-autopsies-reveal-potential-new-culprit-behind-alzheimers-disease
What of freaking joke…. Tried to bag everyone in the hideout.
$AMIH Receives Funding Commitment of Up To $20 Million
Click here:
https://finance.yahoo.com/news/american-international-holdings-corp-receives-132000450.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
About American International Holdings Corp.
American International Holdings Corp. (OTCQB: AMIH) is an investor, developer and asset manager diversified across multiple sectors, with a focus on the energy supply chain. As of the date of this release, the AMIH portfolio includes Cycle Energy Corp., a diversified energy company based in the state of Texas that currently owns and operates three vertically integrated businesses - Cycle Oil and Gas, Cycle Energy Services and Cycle Energy Technologies.
About Cycle Energy Corp.
Cycle Energy Corp. is an energy company based in the state of Texas and currently operates three vertically integrated businesses.
Cycle Oil and Gas. This wholly owned Texas subsidiaryfocuses on acquiring and optimizing underdeveloped oil and gas assets. It employs both internally developed and third party-licensed technologies to increase production, optimize performance and reduce costs. Cycle Oil and Gas currently produces approximately 25 barrels of oil per day from 16 leases on approximately 2,000 acers. The company currently has 125 wells on lease to reactivate. Since acquiring the leases in July 2022, Cycle Oil and Gas has increased production from an average of 7 barrels/day to 25 barrels per day. After reviewing well control data in the area, Cycle Oil and Gas believes that there is more recoverable oil available on these leases.
Cycle Energy Services. This wholly owned Texas subsidiary supports Cycle Energy's overall exploration and production efforts with "well services" and "end of life reclamation." Cycle Energy Services owns and operates a combination of customized service-wireline rigs and HydroVac units. This cutting-edge equipment allows for faster "rig in" and "rig out" times. Overall, Cycle Energy Services' equipment and experience combination seeks to reduce the amount of time and fuel burned to complete an abandonment or workover thus reducing costs.
Cycle Energy Technologies. This wholly owned Texas subsidiary provides both R&D and existing technology to enable increased production in the field. Cycle Energy's flagship intellectual property is its mobile Gas to Liquid system. This is used to convert natural gas and other gaseous hydrocarbons into longer-chain hydrocarbons, such as gasoline or diesel fuel.
Each of Cycle Energy's three vertically integrated businesses operate in tandem to help Cycle Energy capture unique opportunities that often go untapped by the Company's competitors.
To learn more about AMIH., please see our Twitter page at https://twitter.com/CycleNRG.
Peeps
NHYF
Still lots of room to run
Ten bags plus +++++
Happy Sunday!!!!
Yo Frogger!
BTM $176 million revs 2nd qtr preliminary report, filing in a few days 8/14/2023. Warrants @ $11.50. Over 6700 kiosk the largest in the America’s north and south!..Gotta be in early!!
$LLLI: Much Quicker Order Fulfilment Than Competitors for Less Lethal Weapons, Riot Shields and Other Vital Security Products Marketed Worldwide: Lamperd Less Lethal, Inc. (Stock Symbol: LLLI)
by ABNewswire
July 17, 2023 7:07 PM
https://www.benzinga.com/pressreleases/23/07/ab33259191/much-quicker-order-fulfilment-than-competitors-for-less-lethal-weapons-riot-shields-and-other-vi
From the article:
Developer and Manufacturer of Less Lethal Weapons for Riot Control and Related Uses by Police, Corrections, Military and Other Security Forces Worldwide.
Products Manufactured In-House with Local Raw Materials Suppliers for Much Quicker Order Fulfilment Than Competitors Who Outsource Production.
Perfect Safety Record with Zero Deaths in All Company History.
Global Non-Lethal Weapons Market Size Estimated at Over $4.9 Billion in 2023 and Expected to Reach $6.1 Billion by 2028.
Two New Orders for Humane Animal Distraction Products in Canada.
Order Received for Special Munitions Rounds from New International Customer.
Prepared to Deliver Advanced Riot Shields in a Range of Sizes and Types.
My man!
Always solid picks
I’ll add CEOS as a play that could go and sustain
NHYF for a clean shell merger
Let’s go!
hello bro ,
hope all is good with you and getting better !
AI is the trend now !
$MMMW cost cutting news today.
VSMR 1.1M VOLUME 10 DAY AVG_118K .10 +13.64%
Me too. U need stay strong friend ! Things happen in life unexpected but life need move on. My sister in coma and serious brain surgery lately too. Whole year in stress with market and family issues. Life need to move on friend. We are human.
$VIRI looks like it is making progress.
VIRI 376K VOLUME 10 DAY AVG_956K $1.70 +1.81%
VORBQ 4.7M VOLUME 10 DAY AVG_3.9M .0975 +65.25%
VORBQ 2.2M VOLUME 10 DAY AVG_3.9M .087 + 47.76%
VORBQ 2.1M VOLUME 10 DAY AVG_3.9M .0865 + 46.61%
VORBQ 1.5M VOLUME 10 DAY AVG_3.9M .0858 +45.42%
VORBQ 580K VOLUME 10 DAY AVG_3.9M .0705 + 19.62%
VORBQ 559K VOLUME 10 DAY AVG_3.9M .07 + 18.64%
VORBQ 5.2M VOLUME 10 DAY AVG_3.6M .0659 +135.15%
VORBQ 5.1M VOLUME 10 DAY AVG_3.6M .065 +131.94%
VORBQ 4.8M VOLUME 10 DAY AVG_3.6M .0632 +125.51%
VORBQ 4.1M VOLUME 10 DAY AVG_3.6M .0565 +101.61%
VORBQ 4.1M VOLUME 10 DAY AVG_3.6M .0574
VORBQ 3.9M VOLUME 10 DAY AVG_3.6M .052 +85.55%
VORBQ 3.5M VOLUME 10 DAY AVG_3.6M .0506 +80.37%
VORBQ 1.1M VOLUME 10 DAY AVG_3.6M .0449 +60.21%
VORBQ 3.8M VOLUME 10 DAY AVG_3.2M .042 +236%
VORBQ 3.5M VOLUME 10 DAY AVG_3.2M .0426
$GSAC .001 Ready to move into Huge catalyst on/around ~5/31
$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements
https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382
Followers
|
439
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
27508
|
Created
|
02/26/13
|
Type
|
Free
|
Moderator OCKHAM'S RAZOR | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |